Ionis Pharmaceuticals | 4:持股變動聲明-董事 Hayden Michael R
Ionis Pharmaceuticals | 8-K:重大事件
Ionis Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-BB Biotech AG(5.0%),Biotech Invest N.V.(5.0%)
Ionis Pharmaceuticals | 4:持股變動聲明-高管 Swayze Eric
Ionis Pharmaceuticals | 4:持股變動聲明-高管 Monia Brett P
Ionis Pharmaceuticals | 4:持股變動聲明-董事 LOSCALZO JOSEPH
Ionis Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-T. Rowe Price Investment Management, Inc.(9.0%)
Ionis Pharmaceuticals | 144/A:其他
Ionis Pharmaceuticals | 144:擬議出售證券
Ionis Pharmaceuticals | 144:擬議出售證券
Ionis Pharmaceuticals | 144:擬議出售證券
Ionis Pharmaceuticals | SC 13G:超過5%持股股東披露文件-Wellington Management Group LLP(5.76%),Wellington Group Holdings LLP(5.76%)等
Ionis Pharmaceuticals | 10-Q:2024財年三季報
Ionis Pharmaceuticals | 8-K:愛奧尼斯公佈2024年第三季度財務業績
Ionis Pharmaceuticals | 4:持股變動聲明-高管 Swayze Eric
Ionis Pharmaceuticals | 4:持股變動聲明-高管 Devers Shannon L.
Ionis Pharmaceuticals | 4:持股變動聲明-高管 Devers Shannon L.
Ionis Pharmaceuticals | 3:首次持股聲明-高管 Devers Shannon L.
Ionis Pharmaceuticals | 8-K:重大事件
Ionis Pharmaceuticals | 424B5:募資說明書
暫無數據